This little-known cancer screening stock is about to get a big boost, Jefferies says
The investment firm initiated coverage of the disease-detection name at a buy.
Overview
The investment firm initiated coverage of the disease-detection name at a buy.
Source
Originally published at www.cnbc.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.